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Abstract The incessant use of antibiotics against infec-
tious diseases has translated into a vicious circle of
developing new antibiotic drug and its resistant strains in
short period of time due to inherent nature of micro-
organisms to alter their genes. Many researchers have been
trying to formulate inorganic nanoparticles-based antisep-
tics that may be linked to broad-spectrum activity and far
lower propensity to induce microbial resistance than anti-
biotics. The way-out approaches in this direction are
nanomaterials based (1) bactericidal and (2) bacteriostatic
activities. We, herein, present hitherto unreported obser-
vations on microbial abatement using non-cytotoxic
molybdenum disulfide nanostructures (MSNs) which are
synthesized using microwave assisted solvothermal route.
Inhibition of biofilm formation using MSNs is a unique
feature of our study. Furthermore, this study evinces
antimicrobial mechanism of MSNs by reactive oxygen
species (ROS) dependent generation of superoxide anion
radical via disruption of cellular functions.
Keywords Biofilm  Antimicrobial  ROS  Molybdenum
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Introduction
Indiscriminate use of antibiotics against infectious diseases
is turning out to be a vicious cycle of developing new
antibiotic drug and its resistant strains in short time span
due to inherent tendency of microbial cells to alter their
genes. The origin of the multidrug resistant (MDR)
microbes lies in the increased evolutionary selection pres-
sure on microbial population which allows the resistant
microbes to survive and the susceptible ones to perish.
Antibiotic resistance, therefore, poses a significant health-
care threat. There is an urgent and compelling necessity for
making improvements in present methods and develop
novel strategies to tackle the situation. Three possible
solutions emerging in this context are (1) generic approach
for development of conventional and newer antibiotics
based MDR drugs. This approach may not be feasible over
the longer period as there may be a possibility of bacterial
resistance to such drugs. Nevertheless, nanomaterials may
prove useful in designing the next two approaches, namely,
(2) bactericidal (contemporary) approach of exploitation of
inorganic nanoparticles to develop antiseptics that are
deadly to microbes and may demonstrate wide-ranging
activity and lower prospect to promote microbial resis-
tance. However, many nanoparticles have different degrees
of toxicity causing restrictions in their use directly as
antibacterial agents (Jones et al. 2004), and (3)
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bacteriostatic approach which is the least explored but is
significantly emerging and promising. Under this approach,
nanomaterial can be applied as an agent that inhibits the
formation of biofilms without actually killing the microbial
cells. Biofilm growth can cause infection (Bjarnsholt et al.
2010) and has detrimental effects on various materials and
equipments like medical devices, implants, and food-pro-
cessing equipments, thereby causing enormous economic
and health-related damages (Weir et al. 2008).
It may be noted that in the context of drug-resistant
strains and ineptness of traditional treatments, the nano-
material-based approaches do not exert evolutionary pres-
sure on bacteria and hence can be beneficial in the long run.
Nanoparticles, especially metallic ones, tend to offer an
effective solution for overcoming bacterial resistance
(Shinde et al. 2012a). But, metallic nanoparticles have
different degrees of cytotoxicity, which restrict their use in
antimicrobial drugs. In this explicit perspective, we have
stumbled upon the report pertaining to biocompatibility
and non-cytotoxicity of molybdenum disulfide nanoparti-
cles (Wu et al. 2011). However, they cannot be claimed as
complete antimicrobial package unless and until their
capabilities showing profound antimicrobial activity and/or
anti-biofilm ability are established.
Molybdenum disulfide belongs to a family of funda-
mentally and technologically important multifunctional
layered materials. It forms sandwich interlayer structure
created by S–Mo–S layers, which are loosely bound to each
other only by van der Waals forces (Rapoport et al. 2005).
Such structures, at the bulk and nanoscale, exhibit a broad
array of applications, such as electrochemical hydrogen
storage (Chen et al. 2001), cathode material for recharge-
able lithium batteries and solar cells (Imanishi et al. 1992;
Thomalla and Tributsch 2006), electric transport (Kopnov
et al. 2006), useful solid lubricant (Rapoport et al. 2003),
an intercalation host (Aharon et al. 2006), and field emis-
sion tips (Nemanic et al. 2003). For example, molybdenum
disulfide may be an alternative material for next-generation
nanoelectronic devices viz., transistor (Radisavljevic et al.
2011) and tandem photovoltaic configurations because its
electronic properties are superior to silicon (Li et al. 2005)
and its band gap transforms from indirect to direct at
nanoscale. So far, nanoscale molybdenum disulfide has
been obtained with different morphologies such as hollow
micro-tubes and micro-spheres (Afanasiev et al. 2000;
Afanasiev and Bezverkhy 2002), amorphous tube-and ball-
like structures (Peng et al. 2002), nano-wires (Li et al.
2003), randomly stacked layers (Li et al. 2004), etc. for
host of applications. However, synthesis of molybdenum
disulfide nanostructures (MSNs) using a facile and ‘green’
technique is still a prime challenge which is certainly
advantageous from the standpoint of futuristic nano-bio-
technology based (including antimicrobial) applications.
Vide this communication, we present an expedient and
‘green’ microwave-assisted solvothermal synthesis (Shinde
et al. 2012b) of MSNs and hitherto unreported pre-thera-
peutic antimicrobial application protocol of the same.
Fundamentally, the synthesized products were explored for
antimicrobial applications with two-pronged intentions: (1)
to probe biofilm inhibition (in Psuedomonas aeruginosa
01) which is the earliest assertion of MSNs as anti-biofilm
agents and (2) to assay the antibacterial property of syn-
thesized nanoparticles (using model organisms, gram-
positive Bacillus subtilis NCIM 2063 and gram-negative
Escherichia coli NCIM 2931 and corroborate the possible
mechanism by detecting and measuring the reactive oxy-
gen species (ROS) and simultaneously monitoring the
redox enzymes. Additionally, non-cytotoxic nature exhib-




All the reagents were of analytical grade and were used
as received without any further purification. In a typi-
cal experimental procedure, ammonium molybdate
[(NH4)6Mo7O244H2O] and elemental sulfur were mixed in
1:1 molar ratio in 10 ml hydrazine monohydrate and 30 ml
deionized water (DIW) under magnetic stirring for 5 min.
The resultant solvent mixture was transferred to Teflon
vessel and subjected to microwave radiation of 270 Watt in
household microwave oven (Godrej GMC 30E) for 10 min,
and subsequently, was allowed to cool down naturally to
room temperature. Black precipitate settled at the bottom
of the solution was filtered, washed with DI water, diluted
hydrochloric acid and ethanol successively and centrifuged
to remove the unreacted precursors. The final product was
dried in vacuum oven at 50 C for 4 h.
Characterization of MSNs
The resultant samples were extensively characterized for
their structural and morphological features by a variety of
analytical techniques. Wide angle X-ray diffraction
(WAXD) analysis of our sample was accomplished for
accurate phase identification by resolving the overlapping
peaks using Philips X’Pert PRO Diffractometer. Dynamic
light scattering (DLS) measurement was performed using
90Plus zeta sizer (Brookhaven Inc, NY) for measuring the
hydrodynamic diameter of MSNs. Field emission scanning
electron microscopy (FESEM) was used to image as-pre-
pared molybdenum disulfide sample using HITACHI
S-4800. The resultant powder was directly put on the
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conducting carbon sheet without dispersing in any solvent
and coated with conducting gold film. High-resolution
transmission electron microscopy (HRTEM) was carried
out for powder placed on carbon-coated copper grid (using
liquid dispersion of MSNs in isopropyl alcohol) using
JEOL JSM 2100. MSNs were also characterized by AFM
on an Agilent 5500 AFM/SPM microscope under acoustic
AC mode using Si probes operating at a resonant frequency
of 154 kHz. In all the AFM measurements, topography,
phase, and amplitude images were obtained. For clarity,
only the topographic images were compared and presented.
Antimicrobial activity assay
Determination of minimum inhibitory concentration (MIC)
and minimum bactericidal concentration (MBC)
The as-synthesized MSNs were dispersed as colloidal
suspension in sterile distilled water by sonication before
testing for antimicrobial activity. All in vitro antimicrobial
activity study was performed using Gram positive and
negative model organisms viz. Bacillus subtilis NCIM
2063 and Escherichia coli NCIM 2931, respectively. MIC
and MBC are the lowest concentrations (of nanoparticles,
in the present case) at which a tested compound, respec-
tively, inhibits growth or kills more than 3 log (99.9 %) of
bacteria. Since the as-synthesized MSNs in Mueller–Hin-
ton (MH) medium form a suspension, rather than solution,
MBC results were recorded by calculating the colony-
forming units per milliliter (CFU/ml). In short, 24-well
microtiter plates containing one mL MH broth (Hi-Media
Mumbai, India), with nanoparticles (in the concentration
range of 37–1,000 lg/mL) were inoculated with test strains
(final cell density of 5 9 104 CFU/ml) and incubated at
37 C for 15 h. The lowest concentration of nanoparticles
showing visual growth inhibition was considered as the
MIC. The MBC was measured by preparing serial dilutions
from the MIC assay and plating the dilutions on MH agar
plates. The data were recorded as survival rates (CFU/ml),
based on 100 % survival for the untreated control. All MIC
and MBC values reported were based on three experi-
mental repeats (Anon. NCCLS, Wayne, PA, 2000).
Biofilm assay
Psuedomonas aeruginosa PAO1 was grown overnight in
Luria Bertaini (LB) medium at 37 C with agitation. After
growth, the culture was diluted with LB medium (OD600
0.02), and 50 lL of the diluted culture was added to
950 lL of LB medium supplemented with 150 lg/mL of
MSNs and was incubated statically for 18 h at 37 C in
eight-well glass chamber slide. After incubation, plank-
tonic bacteria were discarded, and the biofilms were
washed three times with cacodylate buffer (CB, 0.1 M, pH
7.4). Biofilms formed on glass plates were fixed in 2 %
glutaraldehyde using 0.1 M CB (pH 7.4) for 4 h at 40 C.
After thorough washing with CB, samples were dehydrated
in a series of ethanol solutions (10–100 %). The samples
were dried, mounted on aluminum stubs with conductive
carbon cement, and finally coated with a gold film for
observation under FESEM (Hitachi 4800 SEM at 1.5 kV)
(Liu et al. 2009). For CLSM, after initial through washing,
the biofilm was covered with 50 lL of 100 lg/ml of dye,
concanavalin A, alexaflour 488, and incubated for 30 min
at 4 C. The biofilm was finally washed with cacodylate
buffer of 0.1 M, pH 7.4, and observed under fluorescence
microscopy (Zies, Germany) with an excitation of wave-
length of 488 nm and emission at 519 nm (Applerot et al.
2012). The statistical analysis was also performed using
Image Quanta Analysis (Zies, Germany).
Detection, measurement of ROS, and determination of cell
morphology
The ROS generated by the action of MSNs inside the cells
were fluorometrically assayed by fluorescence microscopy
while its morphology is detected by FESEM. In a typical
experimental procedure, the cells of B. subtilils and E. coli
were grown to mid log phase (1 9 107 cells/mL) and then
treated with MSNs (MIC50 value, i.e., the value where
50 % reduction in the viable cells takes place) for 3 h at
37 C and 150 rpm. The cells were collected by centrifu-
gation at 10,000 rpm for 15 min at 4 C (Foucaud et al.
2007).
Fluorescence microscopy
The cell pellets were washed three times with 0.1 M
phosphate buffer (PB) at pH 7.4 and incubated with 25 lM
DCFH-DA for 30 min. At the end of the incubation, cells
were washed with phosphate buffered saline (PBS) again.
The fluorescence of 20,70-dichlorofluoroscein (DCF), which
is the oxidized product of hydrolyzed 20,70-dichlorofluo-
roscein (DCFH, from DCFH-DA by intracellular ester-
ases), was detected by observing the cells under
microscope (Zeiss) at 1,0009 magnification and measured
with a Varian fluorescence spectrophotometer, using
excitation and emission wavelengths of 485 and 530 nm,
respectively. The DCF concentration in cells not exposed
to nanoparticles was used as a control.
Scanning electron microscopy
The cell pellets were washed three times with 0.1 M PB at
pH 7.4, and fixed in PB containing 2.5 % glutaraldehyde at
4 C for 4 h. After rinsing twice with PB, the pellets were
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dehydrated in ethanol serials (10, 30, 50, 70, 80, 90, and
100 %, 15 min per step) and then dried in air.
Extraction of proteins and assay of antioxidant enzymes
For the extraction of proteins, 300 mL MH broth was
added to MIC50 value (0.15 mg/ml) containing MSNs and
5.0 9 106 cells of B. subtilis and incubated till the density
reached to mid log phase (4 h), upon which it was centri-
fuged at 10,000 rpm for 15 min at 4 C. The cell pellets
were suspended in cell lysis buffer (PB, 0.1 M, pH 7) and
subjected to sonication (10 kHz for 8 min with four
intervals of 2 min each) in ice-cold condition (4 C). The
sonicated sample was centrifuged at 15,000 rpm for
30 min at 4 C and the resulting supernatant was used for
the assay of antioxidant enzymes. The protein extracted
without using nanoparticles was used as control. Total
SOD activity was assayed by monitoring the inhibition of
reduction of nitro blue tetrazolium (NBT). The reaction
mixture of 1 ml contained 50 mM potassium phosphate
buffer (pH 7.8), 13 mM methionine, 75 lM NBT, 2 lM
riboflavin, 0.1 mM Na2EDTA, and known volume (lL) of
enzyme extract corresponding to 250 lg of proteins
(Giannopolitis and Ries 1977). The reaction mixture was
illuminated, perpendicularly, for 15 min under 60 W
fluorescent tubes at a distance of 10 cm. One unit of SOD
activity was defined as the amount of enzyme required to
cause 50 % inhibition of NBT reduction monitored at
560 nm.
Catalase activity was determined by measuring the
consumption of H2O2 (extinction coefficient 39.4
mM-1 cm-1) at 240 nm for 1 min by the method of Aebi.
The reaction mixture contained 50 mM potassium phos-
phate buffer (pH 7.8), 10 mM H2O2, and known volume
(lL) of the enzyme extract corresponding to 100 lg of
proteins in 1 ml volume (Aebi 1984).
Cytotoxicity study
The cytotoxicity of the MSN against HeLa cells was
evaluated by observing cells under microscope and deter-
mining the metabolic activity by 3-[4,5-dimethylthiazol-2-
yl]-2,5 diphenyl tetrazolium bromide (MTT) assay. Briefly,
cells were seeded into a 96-well culture plate at
2 9 104 cells/well in a 100 lL culture medium. After
incubation at 37 C in a 5 % CO2 incubator for 24 h, cells
were exposed to the 300 ug/mL of MSN. The cells were
incubated for 72 h, followed by the observance of cells
morphology under the microscope at 409 magnification
(Ziess, Germany). For MTT assay, cells were washed in
0.1 M PB saline, added with 20 uL of MTT solution
(5 mg mL-1), and incubated in dark for 3 h. 100 uL of
DMSO was added to wells and absorbance was recorded at
550 nm in microplate reader (Thermo-fisher, USA) and
further cultivation for 4 h.
Results and discussion
MSNs synthesis and physico-chemical
characterization
The synthesis of MSNs was carried out via microwave-
assisted solvothermal technique reported for other materials
(Shinde et al. 2012a). The schematic describing the outline
of the work is illustrated in Fig. 1a. Microwave-assisted
solvothermal technique qualifies for the energy efficient
‘greener’ approach by drastically reducing the reaction time
(*300 times faster than the conventional method). Micro-
wave radiation penetrates through Teflon vessel and inter-
acts with the solvents directly causing localized heating and
thus generates supercritical conditions favorable for nucle-
ation and growth of nanoparticles. Wide angle X-ray dif-
fraction (WAXD) analysis of our sample was accomplished
for accurate phase identification by resolving the overlap-
ping peaks using Philips X’Pert PRO Diffractometer
(Fig. 1b). The major diffraction peaks are characteristic of
hexagonal MoS2 (JCPDS # 24-0513). The presence of sec-
ond phase viz. hexagonal Mo15S19 is confirmed by standard
finger-printing with the reported data (JCPDS # 40-0936) as
minor phase. WAXD results disclose that synthesized
powder exhibits symbiotic existence of biphasic compound
comprising MoS2 and rarely occurring Mo15S19. The dif-
fraction peaks are very wide entailing presence of nanoscale
crystallites. The average crystallite size calculated using
Scherrer’s equation is in the range of 1–3 nm. The low-
magnification TEM image reveals rod-shaped elongated
nanoparticles having thickness nearly 10 nm and length
varying from 20 to 40 nm. HRTEM image shows moderate
crystalline nature which can be correlated with substantial
peak broadening as observed in WAXD (Fig. 1c.).
FESEM images reveal formation of spherical and
irregular shaped particles which (Fig. 2a) appeared to be
agglomerated and few irregular shaped plate-like structures
appear to be stacked one above the other. Sizes of these
structures vary from 40 to 150 nm.
The DLS measurements showed an average intensity
weighted particle size *583 nm. The DLS measurement
provides the hydrodynamic size and is expected to be lar-
ger than the physical size measured by other techniques
such as transmission electron microscopy. Moreover, if the
sample is non-homogeneous and a few larger sized nano-
particles are present in the sample, the measurement is
skewed towards the larger size.
Hence in this case, the particle size of MSNs was signif-
icantly larger than obtained by HRTEM. Therefore, particle
334 Appl Nanosci (2015) 5:331–341
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size was measured again after filtering the above samples
using a 0.2-lm syringe filter. A significant change in the
particle size measurement was noted which is reduced to
*155 nm (Fig. 2b). This size is more consistent with what is
expected by TEM measurement. The AFM measurements of
MSNs helped to elucidate the morphology along with the
size. A representative image in Fig. 2c shows some large
aggregated particles in the size range of 200–400 nm.
The height of these particles is in the range of 100 nm.
This indicates that these MSNs are not spherical but have a
plate-like structure. However, for the 0.5 9 0.5 lm image,
several smaller sized nanostructures are seen having size
*20 nm and average height of 2 nm (Fig. 2d). The
obtained morphology is consistent with the larger sized
aggregates in terms of plate-like structure. The AFM
results are consistent with the particle size measurement by
DLS method.
Biofilm inhibition in P. aeruginosa via the effect
of MSNs
FESEM analysis of biofilm (corresponding to P. aerugin-
osa) treated with our MSNs (at a concentration of 150 lg/
mL) was performed to ascertain its morphological
appearance. P. aeruginosa was specifically used as a model
organism in studying the formation of biofilm on account
of its dreadful nuisance in hospitals, particularly, in skin
burns. When cells of P. aeruginosa were grown in presence
of nutrient medium, they adapt to grow, multiply, and
communicate with each other by generation of quorum, and
upon reaching the critical level density of quorum, they
start formation of web-like structure consisting of dense
polysaccharides with cells and their debris embedded
inside (a biofilm). The free suspended cells are called as
planktonic. In sample prepared without MSNs treatment
Fig. 1 Synthesis and
characterization of MSNs.
a Schematic of the strategy for
microwave assisted green
synthesis of MSNs via
generation of supercritical
conditions. b WAXD pattern of
resultant molybdenum sulfide
powder revealing biphasic
nature. The dashed trace and
continuous line depict the
experimental pattern and fitting
function, respectively.
c HRTEM image of MSNs.
(Inset magnified lattice images
at various position indicated by
red circles)
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(control), a web-like mass underneath the cells was
observed, a typical indication of biofilm structure (Fig. 3a),
whereas, for MSNs treated sample, exposed cells with
significantly diminished biofilm underneath are observed
(Fig. 3b). The diminished biofilm in MSN-treated P.
aeruginosa was not due to the inhibition of the growth of
planktonic cells as the number of planktonic cells in the
MNS-treated cells was nearly same as in control. When we
assayed the number of planktonic cells in MNS-treated
samples and control, it was nearly equal, approximately
2.3 9 107 cells/mL. Confocal scanning laser microscopy
(CSLM) analysis also confirmed impedance in biofilm
formation in the presence of MSN (Fig. 3c, d). Under
CSLM, biofilms were seen with patches of fluorescence
Fig. 2 Surface morphology and
particle size determination.
a FESEM image of resultant
MoS2 powder. b DLS particle
size measurement of MSNs
after filtering using 0.2 lm
syringe filter. c AFM image of
MSNs at low magnification and
d representative topographic
image at 0.5 9 0.5 lm area
image of MSNs
Fig. 3 Biofilm inhibition effect
and CSLM analysis.
Representative FESEM image
showing effect of MSNs
treatment on biofilm inhibition
in P. aeruginosa. a Control,
web-like structure beneath the
cells is biofilm and b MSNs
treated, weblike structure is
diminished. Under Confocal
microscopy, biofilm of P.
aeruginosa PA 01. c Control, a
typical biofilm, and d MSNs
treated, a truncated formation of
biofilm
336 Appl Nanosci (2015) 5:331–341
123
(Fig. 3c), a typical of biofilm. However, in the presence of
MSNs (Fig. 3d), the fluorescence was spatially distributed,
indicating truncated formation of biofilm (decrease by
about 40 %). In addition, shrinkage in depth of biofilm
after MSNs treatment, in comparison to control, can be
clearly observed. In comparison to control, the shrinkage in
the depth of biofilm was about 12.5 lm (SD 0.05).
Various nanoparticles have been reported as agents
inhibiting formation of biofilm; however, intriguingly,
most of these nanoparticles displayed this property owing
to inhibition of cell growth (Hetrick et al. 2009). However,
our MSNs impede formation of biofilm in P. aeruginosa
without actually disrupting bacterial cells or their function
(FESEM evidences in Fig. 3a, b). The possible reason for
such behavior would be the inhibition of quorum sensing
(QS) phenomenon. The QS is a phenomenon in which
organisms tend to communicate with each other by
secreting a sense molecule into the surrounding medium.
When the cell density of P. aeruginosa reaches critical
level, they tend to form biofilm. Nevertheless, we speculate
that MNSs somehow interfere in this QS phenomenon, and
thus, inhibit biofilm formation. Growth of the planktonic
cells is not inhibited as the concentration used was insuf-
ficient to hinder the metabolic reactions inside cells.
Peculiarly, the inhibition of biofilm formation by our
MSNs is significant as biofilm protects the pathogenic
organisms from drugs and immune system by resisting
entry and recognition, respectively. Thus, our MSNs can
also be regarded as potential candidate in treating biofilm-
protected infections and prevent any bacterial colonization
on medical devices implanted in tissues of human being.
Assay on bactericidal activity of MSNs
MIC (the minimum concentration at which a visual inhi-
bition of growth) of MSNs against B. subtilis and E. coli
was 300 and 1,000 lg/mL, respectively. Interestingly, the
MBC value too was 300 and 1,000 lg/mL against B.
subtilis and E. coli, respectively (Please see Online
Resource Figure S1 for graphical data). In comparison to B.
subtilis, a higher value of MBC (lower activity) of MSNs in
E. coli is due to the presence of outer layer of lipopoly-
saccharides. The outer layer of lipopolysaccharides is an
extra protective layer in E. coli, which, either hinders the
entry of MNS or absorbs the free radical generated on the
cell wall of these organisms. The antibacterial activity of
MSNs is striking especially because there are very few
reports pertaining to metal-sulfide nanoparticles exhibiting
antimicrobial activity (Li et al. 2010; Yamamoto et al.
1999) and none for MSNs.
In order to probe the possible bactericidal mechanism of
MSNs, we carried out the quantitative determination of ROS
generation in B. subtilis and E. coli cells treated with by
fluorescence microscopy and spectrofluorometry (Fig. 4).
During this assay, hydrophobic 20,70-dichlorfluorescein-dia-
cetate (DCFH-DA) molecules, which readily penetrate cel-
lular membranes, are hydrolyzed by intracellular esterases to
yield DCFH, a non-fluorescent compound; DCFH is then
oxidized by ROS to fluorescent compound, 20,70-dichloroflu-
oroscein (DCF). A relative lower generation of ROS in case of
E. coli in comparison to B. subtilis in the presence of MNS
particle is due to presence of outer envelope in E. coli
(Fig. 4a). As higher reportier of ROS is generated inside B.
subtilis, we decided to continue further studies with B. subtilis.
The generation of ROS in cells of B. subtilis was corroborated
by investigating the specific activities of redox enzymes,
superoxide dismutase (SOD), and catalase (CAT). SOD is the
first enzyme to interplay in antioxidant mechanism that cata-
lyzes the dismutation of superoxide anion radical (O2
-) into
oxygen and hydrogen peroxide. An increase in the specific
activity is an indicator of increase in the biosynthesis of
enzyme. In the present study, specific activity of SOD for
samples treated with MSNs has enhanced from 0.88 (control)
to 3.02 IU, a 3.45-fold increase (Fig. 4b). A 3.45-fold increase
in specific activity is the clear indication of generation of
(O2
-) inside the cells of B. subtilis which has also been
reported as the mechanism of tolerance to oxidative stress by
TiO2 in marine abalone, i.e. Haliotisdiversicolor supertexta
(Zhu et al. 2011). CAT is an important cellular defense, cat-
alyzing the conversion of hydrogen peroxide (H2O2) to water
(H2O) and molecular oxygen (O2). Since there was no change
in the activity of CAT in the presence of MSNs in B. subtilis
(Fig. 4c), the antibacterial activity can be linked with accu-
mulated H2O2—the dominating species in antibacterial action
against various bacteria (Zhang et al. 2007; Stoimenov et al.
2002).
Reported studies on interaction of nanoparticles with
bacterial cells have suggested two main possible reasons for
antibacterial activity: (1) generation of ROS (Dwyer et al.
2009) attacking the cytoplasmic membrane of bacteria and
rupturing the cells and (2) disruption and disorganization of
membranes and/or disruption of cellular function due to
deposition/accumulation of nanoparticles on surface of
bacteria, in the cytoplasm or in the periplasmic region (Nel
et al. 2009). Therefore, in order to test first hypothesis,
FESEM images of the cells were captured (Fig. 4h–k) dur-
ing ROS generation. However, FESEM images corre-
sponding to B. subtilis (Fig. 4i) and E. coli (Fig. 4k)
indicated that there was no rupture of cells, and cell mor-
phologies remained intact like corresponding controls
(Fig. 4h, j), in turn, ruling out possible rupture of the cells by
ROS (Su et al. 2009). Transmission electron microscopic
(TEM) observation of cells of model organism further cor-
roborated FESEM results that there is no cellular rupture (an
insert in Fig. 4h, i). Thus, we conjecture that generated ROS
act on B. subtilis and E. coli by yet unknown mechanisms of
Appl Nanosci (2015) 5:331–341 337
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disruption of cellular function (most probably via damage to
DNA, lipids, or proteins instead of cell wall rupture) in stark
contrast with antimicrobial action of various nanoparticles as
comprehended in Fig. 5. It may be noted that MBC values
for B. subtilis and E. coli (at 300 and 1,000 lg/mL,
respectively) after MSNs treatment in the present study
seems higher since we used complex media for assaying
antimicrobial and antibiofilm activity. We preferred a
complex media because organisms in the environment often
encounter a complex nutritional source, and we felt that
mimicking the condition of environment would best
describe the antimicrobial and antibiofilm assays. A com-
parison about the reported antimicrobial activities of various
nanomaterials against various microorganisms vis-a`-vis the
present work is presented in Fig. 5. However, in comparison
to various reports on nanostructures of Ag, Pd, Fe–Pt, TiO2,
ZnO, MgO, CuO, etc., the MIC and MIB values in present
study are low (Peng et al. 2002; Xie et al. 2011; Stoimenov
et al. 2002; Morones et al. 2005; Ruparelia et al. 2007;
Maenosono et al. 2007; Tsuang et al. 2008; Reddy et al.
2007; Heinlaan et al. 2008; De Windt et al. 2006; Lyon et al.
2005). Besides, they exhibit biofilm inhibition. Furthermore,
noble metal such as Ag, which emerged as one of the best
studied nanoscale inorganic antimicrobial agents (Morones
et al. 2005; Ruparelia et al. 2007), may have limited appli-
cations due to its higher cytotoxicity. On the other hand, the
cytotoxicity studies of MSNs on Hela cell lines confirmed
that MSNs are nontoxic (Fig. 6). When the cells of Hela
were treated with MNS particles, and assayed for metabolic
activeness as a measure of cell number, we found that the
metabolic activity in MNS-treated cells were nearly same as
in control, indicating that they are nontoxic and, therefore,
can be deemed as biocompatible. Similarly, under micro-
scope, control cells were all adhered, uniform and confined
to monolayer, a typical of healthy cells, similar to MNS-
treated cells, (black clusters are the aggregated MSN on cells
in the supplementary image S1). Our cytotoxicity data cor-
relate with previous report on MSN (Wu et al. 2011) as a
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Fig. 4 Investigation of the antimicrobial action, redox enzyme
activity and detection of intracellular ROS generation: a quantitative
measurement of ROS generation for E. Coli and B. Subtilis. The
specific activities of b super oxide dismutase (SOD) and c catalase
(CAT) of B. subtilis in the presence of MSNs. In the presence of
MSNs, there was an increase in the SOD activity by about fourfold
over control, although the CAT activity remained the same. FESEM
images of B. subtilis d control and e treated and E. coli f control and
g treated for determination of cell morphology during ROS gener-
ation. Fluorescence microscopy images using H2DFFDA staining for
control. h B. subtilis and j E. coli showed less fluorescence and for
MSNs treated. i B. subtilis and k E. coli, a green fluorescence was
detected
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Conclusions
Bacterial resistance to conventional medical antibiotics
based on organic molecules is a serious concern for modern
medicine. High prevalence of multidrug-resistant bacteria
among bacteria-based infections decrease effectiveness of
current treatments and may culminate into contagion-
related deaths. In this context, nanoparticles tend to rep-
resent an effective solution for overcoming bacterial
resistance. Precisely focusing on fringe benefits of inor-
ganic chalcogenide nanoparticles, we accomplished hith-
erto unreported synthesis of biocompatible and non-
cytotoxic molybdenum disulfide nanostructures at reduced
reaction time using facile and ‘greener’ microwave-assis-
ted solvothermal route with the aim to study their antimi-
crobial attributes. The formulation containing MSNs
demonstrated biofilm inhibition effect (detected using
confocal microscopy and FESEM) which enhances the
versatility of its applicability. Moreover, by quantitative
determination of MIC and MBC, we established the prima-
facie antibacterial property of our MSNs. We probed the
possible mechanism of the antibacterial activity by
detecting and measuring ROS, analyzing the change in
enzymatic activity of redox enzymes (SOD and CAT) and
Fig. 5 Comparative illustration
showing the antimicrobial effect
of different inorganic
nanoparticles and our MSNs on
various gram-positive and
gram-negative bacteria
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also by observing the morphological images using fluo-
rescence and electron microscopy. Interestingly, we could
realize antimicrobial action by the disruption of cellular
function as against rupture of the cell. Our studies and
recent studies on MSNs have shown that cytotoxicity is not
a major concern for this class of nanoparticles which makes
them a promising candidate for clinical trials in small
animals. It is presumed that combining nanoparticles with
antibiotics not only reduces the toxicity of both agents
towards human cells by decreasing the requirement for
high dosages but also enhances their bactericidal properties
and such a hybrid approach can potentially overcome
nanoparticle toxicity and offer a significant improvement in
the design of anti-bacterial agents. Furthermore, combining
antibiotics with nanoparticles may restore their ability to
destroy bacteria that have acquired resistance to them.
Therefore, such drug formulations based on MSNs may
have vital and unprecedented applications in pharmaceu-
tical and biomedical industry. Additionally, these formu-
lations can be used for external applications and may be
coated on medical devices/apparatus such as catheters and
endoscopes to curtail the biofilm formation. Moreover,
myriad applications of these nontoxic nanostructures may
span areas such as hydrogen generation and storage, photo-
catalysis, hybrid solar cells, drug storage and delivery.
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